Spinal Cord Stimulator Lawsuits involve legal claims against manufacturers of spinal cord stimulator devices used to treat chronic pain.
These lawsuits allege that the devices are defectively designed and improperly marketed without adequate warnings, leading to severe injuries for patients.
Plaintiffs claim they have suffered complications like electric shocks, burns, nerve damage, device malfunctions, and in some cases, paralysis or death.
They seek compensation for medical expenses, pain and suffering, lost wages, and ongoing healthcare costs related to their injuries.
The central argument is that manufacturers failed to conduct proper safety testing and did not adequately warn patients and doctors about potential risks.
Since 2008, the FDA has received over 80,000 adverse event reports related to these devices, including nearly 500 deaths.
These lawsuits aim to hold device makers accountable, obtain compensation for injured patients, and push for improved safety standards and warnings.
The litigation highlights the need for greater scrutiny of medical devices and more transparent communication of risks to patients.
Victims filing these lawsuits seek compensation for medical expenses, pain and suffering, and in some cases, wrongful death.
They also aim to hold Pfizer accountable for alleged negligence in drug safety and transparency.
These legal actions come in the wake of Pfizer's global recall of Oxbryta in September 2024, following data that showed the drug's risks outweighed its benefits.
The lawsuits not only pursue compensation but also advocate for stricter drug safety measures and more thorough pre-market testing.
Free Case Criteria Guide
%20(2).png)
.png)
.png)
.gif)
